Warning Letter Close-Outs – October 2022
The US FDA released one close-out letter in October, resolving a 2021 COVID-related warning letter.
You may also be interested in...
Sigrid Therapeutics co-founder and CEO Sana Alajmovic took time out of what's been an "exciting" year for the company, which makes silica-based products to treat diabetes and related conditions, to speak with Medtech Insight about her experiences as a Bosnia-born working mom in Sweden. This article is the first in a series for International Women's Day.
With specific and enforceable regulations for artificial intelligence in the life sciences unlikely anytime soon, companies need to follow their own ethical principles.
The German major's internal R&D fortunes in the cardiovascular space have been mixed, with asundexian faltering in a recent atrial fibrillation trial, so getting hold of the European rights to BridgeBio's recently-filed ATTR-CM therapy is a timely boost.